Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Duke Researchers Awarded $1 Million For Prostate Cancer Research

A team of researchers led by Duke Cancer Institute scientists Steven Patierno, PhD; Daniel George, MD; Jennifer Freedman, PhD; Jiaoti Huang, MD, PhD and Amanda Hargrove, PhD have been awarded a Movember Foundation-Prostate Cancer Foundation Challenge Award. The project includes a number of key co-...

Honeycutt Teams With V Foundation In The Race For A Cure

After the loss of her dad, Don Painter, in 2014 to colon cancer, Wanda P. Honeycutt, RN, BSN, CCRP, began running. She participated in her first competitive race a year later when she took part in the 2015 CRUSH Colorectal 5K. That gateway competetive run led to her participation in several half...

Duke Team Finds Missing Immune Cells That Could Fight Lethal Brain Tumors

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses. Where the T-cells go has been unclear, even as immunotherapies are increasingly employed to stimulate the body’s...

Researchers Solve Mystery Of How ALL Enters the Central Nervous System

A deadly feature of acute lymphoblastic leukemia (ALL) is its invasion of the central nervous system. ALL in the central nervous system is very difficult to treat, because most drugs are blocked from the organ system due to a "blood-brain barrier" designed to protect the brain. How cancer cells...

Duke Surgeon Champions Equity In Breast Cancer Support And Care 

On an icy day in January a diverse group of female veterans – eight in all – braved the elements to attend the Durham Veterans Affairs Medical Center (VAMC) for the hospital’s first-ever Breast Cancer Support Group gathering. Duke breast surgical oncologist Oluwadamilola “Lola” Fayanju, MD, MA,...

LeBlanc Receives International Clinical Impact Award

Thomas LeBlanc, MD , a practicing hematologic oncologist and palliative care physician at Duke Cancer Institute, recently received the 2018 European Association of Palliative Care (EAPC) Clinical Impact Award. The European Association for Palliative Care is a membership organization dedicated to...

Sound Waves Could Provide New Tool To Fight Cancer

Sound waves may become the next effective tool to help doctors diagnose cancer and develop more personalized diagnostics and treatments. A new study conducted by researchers from Duke University, MIT and Singapore's Nanyang Technological University shows that sound waves are capable of rapidly and...

Poliovirus Therapy for Recurrent Glioblastoma Has Three-Year Survival Rate of 21 Percent

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial. Comparatively, just four percent of patients at Duke with...

Can Your Treatment Regimen Affect Your Cardiovascular Health?

Nestled in the woods of Duke Forest, you will find the Center for Living Campus at Duke University. It’s an early spring morning as Harry “Randy” Chambers arrives for his weekly exercise appointment. Once inside the building’s walls, Chambers begins to warms up with a brisk walk around the track. “...

Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified. Now scientists at Duke Cancer Institute have identified mutations for the vast majority of the remaining 20 percent of...

Patient’s Advice: Nourish The Soul     

Nadine Tolman takes a sip of water from a plastic cup that her husband, Fay, has just brought her from the refreshment station. “Remember, you need to stay hydrated,” he says softly, laying his hand on her shoulder, “and don’t forget to eat your lunch.” The gentle gesture from her husband disrupts...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute. The blood tests, dubbed “liquid biopsies”, detect...

Pages